The link you have selected will take you away from the TAVNEOS® (avacopan) website to one that is not owned or controlled by ChemoCentryx. ChemoCentryx accepts no responsibility for the content of linked sites.
The link you have selected will take you away from the TAVNEOS® (avacopan) website to the patient support program enrollment website
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click “OK” if you are a healthcare professional.
Based on your location, you are being redirected to the website of our licensee Vifor Fresenius Medical Care Renal Pharma Ltd. CCXI does not have responsibility for, or control of, the contents, availability, operation, or performance of the website.
We’re committed to helping you start and stay on TAVNEOS® (avacopan).
That’s
why we created
TAVNEOS Connect—a patient support
program that was designed with you in mind.
Click below for a digital brochure to learn more.
The TAVNEOS Connect Team is here to:
TAVNEOS Connect services are only available for eligible patients whose diagnosis is aligned to the indication statement on the Food and Drug Administration (FDA)-approved TAVNEOS label. Additional eligibility criteria may apply.
Call the TAVNEOS Connect Team at:
1-833-828-6367 (choose option 2)
We’re available Monday through Friday
from 8
AM to 8 PM ET.
The TAVNEOS Connect Copay Program may help you lower your monthly out-of-pocket costs. Eligible commercially-insured patients may pay as little as $10 for a 30-day supply of TAVNEOS®.
Terms, conditions, and program maximums apply. Other restrictions may apply. This program is not open to patients receiving prescription reimbursement under any federal, state or government funded healthcare program, or for cash patients. This is not insurance or a guarantee of payment. No cash value. Void where prohibited by law.
There are organizations who provide education, support, and
resources that may help you or your loved one throughout
the journey with ANCA‑associated vasculitis. Visit
the sites of these key organizations to learn more.
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention, and treatment of kidney disease.
The Vasculitis Foundation supports, inspires, and empowers people and families living with vasculitis through a wide range of eduation, research, clinical, and awareness initiatives.
NORD is a patient advocacy organization committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.
TAVNEOS can cause serious side effects, including:
Your healthcare provider will do blood tests to check how well your liver is working before starting and during your treatment with TAVNEOS.
including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAVNEOS and certain other medicines may affect each other and cause side effects. Keep a list of the medicines you take and show it to your healthcare provider and pharmacist.
The most common side effects of TAVNEOS include:
TAVNEOS is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active anti-neutrophil cytoplasmic autoantibody(ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA], formerly known as Wegener’s granulomatosis, and microscopic polyangiitis [MPA]).
It is not known if TAVNEOS is safe and effective in children under the age of 18.
These are not all the possible side effects of TAVNEOS. Call your doctor for medical advice about side effects. Please see the Full Prescribing Information and Medication Guide for further details.
TAVNEOS is available as a 10 mg capsule.
You are encouraged to report negative side effects to 1-833-828-6367 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-332-1088.
IMPORTANT SAFETY INFORMATION
TAVNEOS can cause serious side effects, including:
TAVNEOS is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active